Ex Parte SATO et al - Page 5



          Appeal No. 1999-0736                                                        
          Application 08/167,581                                                      

          “less than 2 microns, and the remaining reactants preferably have           
          an average particle size ranging from submicron to 2 microns”               
          (col. 6, lines 2 to 7).  This disclosed range includes                      
          appellants’ claimed range of 1 micron or less.                              
               Where, as here, the difference between the claimed invention           
          and the prior art is some range or other variable within the                
          claims, “the applicant must show that the particular [claimed]              
          range is critical, generally by showing that the claimed range              
          achieves unexpected results relative to the prior art range.”               
          In re Woodruff, 919 F.2d 1575, 1578, 16 USPQ2d 1934, 1936-37                
          (Fed. Cir. 1990).  On page 8 of their brief, appellants assert              
          that “[t]he effect by [sic: of ?] the present invention is made             
          by the synergistic function of the particle diameter and the                
          degassing, and could not be expected by those skilled in the art            
          even if all cited references were combined,” and on pages 6 to 8            
          of their brief they describe experiments “[t]o prove the                    
          criticality of the claimed particle size.”  However, these                  
          statements in the brief are insufficient to constitute such                 
          evidence as would be required to establish criticality, since               
          they were not submitted in the form of an affidavit or                      
          declaration under 37 CFR 1.132.  In re Geisler, 116 F.3d 1465,              

                                          5                                           




Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007